Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer
Clinical trial NCT00006104 · COMPLETED
Trial details
- NCT number
- NCT00006104
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-09-01
- Primary completion
- 2003-07-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.